OncoLab Diagnostics has secured the following intellectual property rights:
Cancer Diagnosis and Prognosis
Publication No.: WO2020182517A1
A method of identifying an SCLC patient at risk of disease progression comprising determining the RNA-expression of at least one marker selected from a neuroendocrine marker and/or DLL3 in a fraction of a blood sample of said patient which blood fraction is enriched in circulating tumor cells (CTCs), wherein said at least one marker is indicative of the patient’s prognosis.
Method and kit for diagnosis of a cancerous disease, method for determining the reaction of a patient to the treatment for a cancerous disease medicament for the prophylaxis or treatment of a cancerous disease
Publication No.: WO2006018290, EP1786929
Diagnostic tests for circulating tumor cells in ovarian cancer.